About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
Lyell Immunopharma Announces Positive Clinical Data for LYL314 in Large B-cell Lymphoma
Lyell Immunopharma announced positive Phase 1/2 clinical trial data for LYL314, a dual-targeting CD19/CD20 CAR T-cell therapy, in patients with relaps...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
Lyell Immunopharma Announces Positive Clinical Data for LYL314 in Large B-cell Lymphoma